Description
Mesla 800mg Tablets (30’s)
Mesla 800mg Tablets contain Mesalamine (5-aminosalicylic acid), a well-established anti-inflammatory agent used in the treatment and maintenance of remission in Ulcerative Colitis and other inflammatory bowel diseases (IBD). Each tablet delivers 800mg of Mesalamine in a delayed-release formulation, ensuring targeted action in the colon where inflammation occurs.
Mesla works by inhibiting the production of inflammatory mediators such as prostaglandins and leukotrienes in the intestinal lining. This helps to reduce symptoms like rectal bleeding, abdominal pain, and diarrhea, while promoting mucosal healing.
Indications include:
-
Treatment of mild to moderate ulcerative colitis
-
Maintenance of remission in ulcerative colitis
-
Adjunct therapy in Crohn’s disease
The high-strength 800mg formulation allows for fewer tablets per dose, improving patient compliance and convenience—especially for long-term maintenance therapy.
Dosage: As prescribed by a healthcare professional. Tablets should be swallowed whole, not crushed or chewed, to ensure proper release in the lower gastrointestinal tract.
Mesla 800mg is manufactured under strict pharmaceutical quality standards to ensure safety, efficacy, and consistency. It is a reliable choice for gastroenterologists managing chronic IBD cases in both outpatient and hospital settings.
Note: For use under medical supervision. Periodic renal function monitoring is advised during prolonged treatment.
Reviews
There are no reviews yet.